Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Raveendra K. Hunnur is active.

Publication


Featured researches published by Raveendra K. Hunnur.


European Journal of Medicinal Chemistry | 2011

One-pot synthesis of pyrazoline derivatised carbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities.

Tasneem Taj; Ravindra R. Kamble; Tegginamath Gireesh; Raveendra K. Hunnur; Sheetal B. Margankop

Novel tricyclic carbazoles 4a-k were synthesized in one-pot employing sydnone derivatives 3a-k as masked hydrazines by the ring transformation in presence of conc. HCl and cyclohexanone. The title compounds were screened for anti-tubercular, anti cancer, DNA cleavage, antioxidant activity. MIC, GI50, LC50, TGI were evaluated. The title compounds have exhibited significant antitubercular, DNA cleavage and antioxidant activities and partial anticancer activity.


European Journal of Medicinal Chemistry | 2013

Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives

Pramod P. Kattimani; Ravindra R. Kamble; Mahadevappa Y. Kariduraganavar; Atukuri Dorababu; Raveendra K. Hunnur

A series of novel 2-(4-chlorophenyl)-5-methyl-4-(2-amine/oxy-ethyl)-2,4-dihydro-[1,2,4]triazol-3-one (5a-t) were synthesized and in vitro anticancerous action of the resulting compounds was studied against NCI-60 Human Tumor Cell Line at a single high dose (10(-5) M) concentration for primary cytotoxicity assay. Among the tested compounds (5a-e, 5g-h, 5k, 5p), the compound 5g (NSC: 761736/1) was further evaluated for five dose criteria at five different minimal concentrations against the full panel of 60 human tumor cell lines which exhibited activity against Leukemia (GI50: 1.10 μM), Non-Small Cell Lung Cancer (GI50: 1.00 μM), Renal Cancer (GI50: 1.00 μM), Colon Cancer (GI50: 1.66 μM), CNS Cancer (GI50: 1.36 μM), Melanoma (GI50: 1.82 μM), Ovarian Cancer (GI50: 1.64 μM) and Breast Cancer (GI50: 1.69 μM).


Journal of Chemical Research-s | 2005

1,3-Dipolar cycloaddition reactions in heterocyclic synthesis. Synthesis of [1-[4-(thiazolyl/imidazothiazolyl/triazolyl)phenyl]-1H-pyrazole-3,4-dicarboxylate esters from 3-(4-acetylphenyl)sydnone

Raveendra K. Hunnur; Prashant R. Latthe; Bharati V. Badami

Cycloaddition of 3-(4-acetylphenyl)sydnone (1) with DMAD gave dimethyl 1-(4-acetylphenyl)-1H-pyrazole-3,4-dicarboxylate (2), which on bromination yielded the corresponding monobromoacetyl (3) and dibromoacetyl (4) derivatives. Both compounds 3 and 4 on reaction with thiourea and thioacetamide afforded the 2-amino- (5) and the 2-methyl- (6) thiazole derivatives respectively, while compound 3 on reaction with 2-aminothiazole gave the imidazothiazole 7. Compound 3 was converted into its azide (8), which on 1,3-dipolar cycloaddition with DMAD afforded the 1,2,3-triazole-4,5-dicarboxylate (9).


Main Group Chemistry | 2011

An expeditious synthesis of 1,2,4-triazolinones appended to 1,3-thiazoles using zinc triflate as catalyst

Pramod P. Kattimani; Shraddha V. Raikar; Ravindra R. Kamble; Mahadevappa Y. Kariduraganavar; Raveendra K. Hunnur

A convenient and high yielding method was developed for the ring transformation of 1,3,4-oxadiazolinones (2a-e) from 3-arylsydnones (1a-e) to 1,2,4-triazolinones (3a-e) using zinc triflate as catalyst and then appended to 1,3-thiazoles via an imino bridge in one-pot reaction with excellent yields. The novel compounds were further scored for c logP values, drug likeliness, drug score and toxicity rates using molecular OSIRIS property explorer. Selective compounds were also screened for antimicrobial studies.


Journal of Heterocyclic Chemistry | 2017

C5 -Alkyl-1,3,4-Oxadiazol-2-ones Undergo Dealkylation upon Nitrogen Insertion to Form 2H -1,2,4-Triazol-3-ones: Synthesis of 1,2,4-Triazol-3-one Hybrids with Triazolothiadiazoles and Triazolothiadiazines: Synthesis of Novel 1,2,4-Triazolin-3-one Derivatives

Pramod P. Kattimani; Ravindra R. Kamble; Atukuri Dorababu; Raveendra K. Hunnur; Atulkumar A. Kamble; H. C. Devarajegowda


Acta Crystallographica Section E: Crystallographic Communications | 2005

5-Phenoxy­methyl-1,3,4-oxadiazole-2(3H)-thione

S. Thamotharan; V. Parthasarathi; G. Anandha Babu; Raveendra K. Hunnur; Bharati V. Badami; Anthony Linden


Arabian Journal of Chemistry | 2017

TiCl4: An efficient catalyst for one-pot synthesis of 1,2-dihydro-1-aryl-naphtho-[1,2-e][1,3]oxazin-3-one derivatives and their drug score analysis

Raveendra K. Hunnur; Ravindra R. Kamble; Atukuri Dorababu; B. Sunil Kumar; Chinna Bathula


Chemistry of Heterocyclic Compounds | 2011

Facile TICl 4 -catalyzed synthesis of novel 1,2,4-triazoles appended to thiazoles

Tegginamath Gireesh; Ravindra R. Kamble; Raveendra K. Hunnur; Tasneem Taj; Mahadevappa Y. Kariduraganavar


Acta Crystallographica Section E: Crystallographic Communications | 2003

3‐[4‐(1‐Oxo‐3‐phenyl­prop‐2‐en‐1‐yl)­phenyl]­sydnone

S. Thamotharan; V. Parthasarathi; Raveendra K. Hunnur; Prashant S. Shinge; Bharati V. Badami; Kurt Schenk


Acta Crystallographica Section E: Crystallographic Communications | 2005

Dimethyl 1-{4-[4,5-bis­(methoxy­carbon­yl)-1,2,3-triazol-1-ylmethyl­carbon­yl]phen­yl}-1H-pyrazole-3,4-dicarboxyl­ate

Michael Bolte; T. V. Sundar; Raveendra K. Hunnur; Bharati V. Badami; V. Parthasarathi

Collaboration


Dive into the Raveendra K. Hunnur's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Thamotharan

Bharathidasan University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge